|
Volumn 2, Issue 1, 2002, Pages 37-50
|
Defining HIV-1 protease substrate selectivity
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ASPARTIC PROTEINASE;
ASPARTIC PROTEINASE INHIBITOR;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
PROTEINASE;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG TARGETING;
ENZYME SPECIFICITY;
ENZYME STRUCTURE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN IMMUNODEFICIENCY VIRUS 1;
NONHUMAN;
QUALITY OF LIFE;
REVIEW;
SURVIVAL RATE;
VIRUS INFECTION;
VIRUS MUTANT;
ANIMAL;
CHEMICAL STRUCTURE;
DIMERIZATION;
DRUG EFFECT;
ENZYMOLOGY;
HUMAN;
METABOLISM;
ANIMALS;
DIMERIZATION;
HIV PROTEASE;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
MODELS, MOLECULAR;
SUBSTRATE SPECIFICITY;
|
EID: 0035984976
PISSN: 15680053
EISSN: None
Source Type: Journal
DOI: 10.2174/1568005024605837 Document Type: Review |
Times cited : (32)
|
References (90)
|